Title of Activity: DNP Managing the Common (and Uncommon) Comorbidities of Atopic Dermatitis- Volume 2 Issue #1

Faculty:
Keischa Cash, DNP, APRN, DCNP, FNP-BC
Megan Lewis, MSN, RN, CPNP-PC,
Patricia Delgado, DNP, AGPCNP, DCNP
Noreen H. Nicol, PhD, RN, FNP, NEA-BC

Release Date: 7/14/2023
Expiration Date: 7/14/2024

Target Audience:
This activity has been designed to meet the educational needs of nurses, nurse practitioners, and physician assistants. Other healthcare providers may also participate.

CREDIT INFORMATION
Estimated time for completion: 75 minutes
THERE IS NO FEE FOR THIS ACTIVITY
This activity is awarded 1.25 Nursing Continuing Professional Development/Continuing Education (NCPD/CE) Credits, which includes 0.25 ANCC Pharmacology Credits.

To Receive Credit:
1. Review the brochure in its entirety - CLICK HERE
2. Complete/submit the post test and evaluation.
3. Receive a passing score of 70% or more to receive credit.
4. Print out your certificate, as well as save it to your computer.

ACCREDITATION STATEMENT:
The Dermatology Nurses’ Association (DNA) is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.

This educational activity is jointly provided by Dermatology Nurses’ Association and Excalibur Medical Education.

PROGRAM OVERVIEW
Program Purpose: The purpose of this activity is to explore the phenomenon of the “atopic march,” including how it manifests in children with AD and how it can be prevented. We will also discuss other common and serious comorbidities associated with AD in children and adults, including infection, autoimmune diseases, and mental health disorders. We will conclude by considering the financial burden experienced by patients with AD, caused in part by the multitude of conditions that many must contend with.

Learning Objectives
Upon successful completion of this educational program, the participant should be able to:
· Identify the most common comorbidities faced by patients with atopic dermatitis (AD).
· Discuss the relationship between AD and other atopic conditions.
· Develop strategies to reduce the risk of skin, soft tissue, and systemic infections among patients with AD.
· Assess the impact of mental health conditions among patients with AD.

DISCLOSURE
It is the policy of DNA to ensure independence, balance, objectivity, scientific rigor, and integrity in all of its continuing education activities. The author must disclose to the participants any significant relationships with ineligible companies whose products or devices may be mentioned in the activity or with the commercial supporter of this continuing education activity. Identified conflicts of interest are mitigated by DNA prior to accreditation of the activity.

Planning committee members:
Linda Markham, BSN, RN, DNC, Executive Director & Program Director, Dermatology Nurses’ Association
Scott Kober, MBA, Managing Director, Excalibur Medical Education
Kristin Harper, PhD, MPH, ELS, Medical Writer
Lynn Smith, DNP, NP-C, DCNP, Content Expert
Trudy Adamson, RN, MSN, DNC, AP-PD, Nurse Planner
have disclosed that they have no relevant financial relationships or conflicts of interest with ineligible companies related directly or indirectly to this educational activity.

Faculty:
Keischa Cash, Megan Lewis, and Patricia Delgado have disclosed that they have no relevant financial relationships or conflicts of interest with ineligible companies related directly or indirectly to this educational activity.

Noreen H. Nicol, PhD, RN, FNP, NEA-BC, has disclosed the following relevant financial relationships specific to the subject matter of the content of the activity: Medline Industries/Advisory Board, Consultant.

All of the relevant financial relationships listed for these individuals have been mitigated.

Off-Label Product Disclosure

This activity includes discussion of investigational and/or off-label use of the following products: Baricitinib, nemolizumab

COMMERCIAL SUPPORT

Support for this activity has been made possible through educational grants from Incyte and Pfizer, Inc.

Megan Lewis MSN, RN, CPNP-PC

Appearances